Earnings Summary

Edwards Lifesciences Corp.’s revenue fell -8.54% since last year same period to $1354.4Mn in the Q3 2024. On a quarterly growth basis, Edwards Lifesciences Corp. has generated -2.27% fall in its revenue since last 3-months.

Edwards Lifesciences Corp.’s net profit jumped 697.82% since last year same period to $3070.8Mn in the Q3 2024. On a quarterly growth basis, Edwards Lifesciences Corp. has generated 738.33% jump in its net profits since last 3-months.

Edwards Lifesciences Corp.’s net profit margin jumped 772.33% since last year same period to 226.73% in the Q3 2024. On a quarterly growth basis, Edwards Lifesciences Corp. has generated 757.83% jump in its net profit margins since last 3-months.

Edwards Lifesciences Corp.’s earning per share (EPS) estimates for the current quarter stand at 0.64 - a -7.25% fall from last quarter’s estimates.

Edwards Lifesciences Corp.’s earning per share (EPS) estimates for the current year stand at 0.64.

Edwards Lifesciences Corp.’s earning per share (EPS) jumped 13.56% since last year same period to 0.67 in the Q3 2024. This indicates that the Edwards Lifesciences Corp. has generated 13.56% annual rate of jump in its earning per share (EPS) in the last 4 quarters.